M, A., L, C., E, C., T, L., D, P., AM, M., & BK, T. (2019). Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer. Scientific reports, 9(1), 13924. https://doi.org/10.1038/s41598-019-50436-1
Chicago Style (17th ed.) CitationM, Asare-Werehene, Communal L, Carmona E, Le T, Provencher D, Mes-Masson AM, and Tsang BK. "Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer." Scientific Reports 9, no. 1 (2019): 13924. https://doi.org/10.1038/s41598-019-50436-1.
MLA (9th ed.) CitationM, Asare-Werehene, et al. "Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer." Scientific Reports, vol. 9, no. 1, 2019, p. 13924, https://doi.org/10.1038/s41598-019-50436-1.